The occurrence of ACL antibodies in anti-TNF alpha-treated patient is well documented [13]: up to 25% of RA patients with anti-TNF develop IgG or IgM ACL, but thrombosis is observed in much fewer patients (about 4%). The gene discussed is CD40LG; the disease is rheumatoid arthritis.